Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Filamon LTD
Ensem Therapeutics
Atavistik Bio, Inc
Eisai Inc.
PMV Pharmaceuticals, Inc
AstraZeneca
NiKang Therapeutics, Inc.
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
NeoImmuneTech
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Alterome Therapeutics, Inc.
Hoffmann-La Roche
Rutgers, The State University of New Jersey
AstraZeneca
BeOne Medicines
National Institutes of Health Clinical Center (CC)
University of California, Davis
Bayer
Genmab
Genmab
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Eli Lilly and Company
ViroMissile, Inc.
Arcus Biosciences, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Genmab
Jazz Pharmaceuticals
Kaiser Permanente
Accent Therapeutics
Duke University
AstraZeneca
Tizona Therapeutics, Inc
University of Florida
Essen Biotech
Essen Biotech
AstraZeneca
Clasp Therapeutics, Inc.
Normunity AccelCo, Inc.
Karolinska Institutet